US Stock MarketDetailed Quotes

AGE AgeX Therapeutics

Watchlist

11.1000
0.00000.00%

Trading Mar 26 16:00 ET

27.76MMarket Cap-809P/E (TTM)

AgeX Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-31.34%-7.8M

-55.34%-2.05M

-50.81%-1.86M

-15.64%-2.02M

-14.00%-1.87M

23.52%-5.94M

19.79%-1.32M

34.39%-1.24M

-3.07%-1.75M

35.59%-1.64M

Net income from continuing operations

-40.76%-14.81M

-25.24%-3.46M

-121.22%-5.39M

-2.33%-2.68M

-21.35%-3.29M

-22.61%-10.52M

-27.88%-2.76M

-24.60%-2.44M

-5.78%-2.62M

-35.83%-2.71M

Operating gains losses

-116.89%-38K

-1,560.00%-73K

--0

-97.02%5K

-65.52%30K

141.44%225K

--5K

---35K

--168K

116.02%87K

Depreciation and amortization

-0.76%131K

0.00%33K

-3.03%32K

0.00%33K

0.76%132K

0.00%33K

3.13%33K

0.00%33K

Other non cash items

68.47%5.29M

-87.45%115K

268.82%3.19M

13.32%919K

94.30%1.06M

181.60%3.14M

211.56%916K

206.01%866K

200.37%811K

103.75%544K

Change In working capital

258.36%1.18M

72.85%643K

240.94%433K

62.43%-127K

36.90%230K

137.22%329K

576.92%372K

124.61%127K

-276.04%-338K

134.85%168K

-Change in receivables

-352.38%-53K

433.33%10K

-654.55%-61K

108.33%1K

-112.00%-3K

-83.59%21K

-200.00%-3K

184.62%11K

-132.43%-12K

-76.19%25K

-Change in prepaid assets

21.88%1.09M

-290.00%-39K

40.41%410K

9.70%407K

29.22%314K

17.89%896K

-112.82%-10K

39.05%292K

4.51%371K

107.69%243K

-Change in payables and accrued expense

205.51%1.22M

75.97%681K

190.91%448K

52.17%-176K

17.70%266K

151.68%399K

352.94%387K

138.31%154K

-385.27%-368K

165.32%226K

-Change in other current liabilities

-9.32%-1.08M

-350.00%-9K

-10.30%-364K

-9.12%-359K

-6.44%-347K

1.30%-987K

0.00%-2K

-6.11%-330K

0.00%-329K

8.94%-326K

Cash from discontinued investing activities

Operating cash flow

-31.34%-7.8M

-55.34%-2.05M

-50.81%-1.86M

-15.64%-2.02M

-14.00%-1.87M

24.39%-5.94M

19.79%-1.32M

34.39%-1.24M

-3.07%-1.75M

37.79%-1.64M

Investing cash flow

Cash flow from continuing investing activities

-10M

Net other investing changes

---10M

--0

---10M

----

Cash from discontinued investing activities

Investing cash flow

---10M

--0

---10M

--0

Financing cash flow

Cash flow from continuing financing activities

191.67%17.5M

33.33%2M

100.00%2M

0.00%2M

666.67%11.5M

-19.96%6M

0.00%1.5M

-50.00%1M

33.33%2M

-39.90%1.5M

Net issuance payments of debt

191.67%17.5M

33.33%2M

100.00%2M

0.00%2M

666.67%11.5M

-14.29%6M

0.00%1.5M

-50.00%1M

33.33%2M

-25.00%1.5M

Cash from discontinued financing activities

Financing cash flow

191.67%17.5M

33.33%2M

100.00%2M

0.00%2M

666.67%11.5M

-17.20%6M

0.00%1.5M

-50.00%1M

33.33%2M

-33.21%1.5M

Net cash flow

Beginning cash position

9.62%695K

-13.37%447K

-58.64%311K

-33.73%330K

9.62%695K

9.88%634K

-33.93%516K

13.08%752K

-42.03%498K

9.88%634K

Current changes in cash

-591.80%-300K

-129.05%-52K

157.63%136K

-107.48%-19K

-168.38%-365K

7.02%61K

221.77%179K

-303.45%-236K

230.93%254K

-148.23%-136K

End cash Position

-43.17%395K

-13.37%447K

-58.64%311K

-33.73%330K

9.62%695K

-33.93%516K

13.08%752K

-42.03%498K

Free cash flow

-31.34%-7.8M

-55.34%-2.05M

-50.81%-1.86M

-15.64%-2.02M

-14.00%-1.87M

24.39%-5.94M

19.79%-1.32M

34.39%-1.24M

-3.07%-1.75M

37.79%-1.64M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-31.34%-7.8M	-55.34%-2.05M	-50.81%-1.86M	-15.64%-2.02M	-14.00%-1.87M	23.52%-5.94M	19.79%-1.32M	34.39%-1.24M	-3.07%-1.75M	35.59%-1.64M
Net income from continuing operations	-40.76%-14.81M	-25.24%-3.46M	-121.22%-5.39M	-2.33%-2.68M	-21.35%-3.29M	-22.61%-10.52M	-27.88%-2.76M	-24.60%-2.44M	-5.78%-2.62M	-35.83%-2.71M
Operating gains losses	-116.89%-38K	-1,560.00%-73K	--0	-97.02%5K	-65.52%30K	141.44%225K	--5K	---35K	--168K	116.02%87K
Depreciation and amortization	-0.76%131K	0.00%33K	0.00%33K	-3.03%32K	0.00%33K	0.76%132K	0.00%33K	3.13%33K	0.00%33K	0.00%33K
Other non cash items	68.47%5.29M	-87.45%115K	268.82%3.19M	13.32%919K	94.30%1.06M	181.60%3.14M	211.56%916K	206.01%866K	200.37%811K	103.75%544K
Change In working capital	258.36%1.18M	72.85%643K	240.94%433K	62.43%-127K	36.90%230K	137.22%329K	576.92%372K	124.61%127K	-276.04%-338K	134.85%168K
-Change in receivables	-352.38%-53K	433.33%10K	-654.55%-61K	108.33%1K	-112.00%-3K	-83.59%21K	-200.00%-3K	184.62%11K	-132.43%-12K	-76.19%25K
-Change in prepaid assets	21.88%1.09M	-290.00%-39K	40.41%410K	9.70%407K	29.22%314K	17.89%896K	-112.82%-10K	39.05%292K	4.51%371K	107.69%243K
-Change in payables and accrued expense	205.51%1.22M	75.97%681K	190.91%448K	52.17%-176K	17.70%266K	151.68%399K	352.94%387K	138.31%154K	-385.27%-368K	165.32%226K
-Change in other current liabilities	-9.32%-1.08M	-350.00%-9K	-10.30%-364K	-9.12%-359K	-6.44%-347K	1.30%-987K	0.00%-2K	-6.11%-330K	0.00%-329K	8.94%-326K
Cash from discontinued investing activities
Operating cash flow	-31.34%-7.8M	-55.34%-2.05M	-50.81%-1.86M	-15.64%-2.02M	-14.00%-1.87M	24.39%-5.94M	19.79%-1.32M	34.39%-1.24M	-3.07%-1.75M	37.79%-1.64M
Investing cash flow
Cash flow from continuing investing activities	-10M	0	0	0	-10M	0	0	0	0	0
Net other investing changes	---10M	--0	--0	--0	---10M	----	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	---10M	--0	--0	--0	---10M	--0	--0	--0	--0	--0
Financing cash flow
Cash flow from continuing financing activities	191.67%17.5M	33.33%2M	100.00%2M	0.00%2M	666.67%11.5M	-19.96%6M	0.00%1.5M	-50.00%1M	33.33%2M	-39.90%1.5M
Net issuance payments of debt	191.67%17.5M	33.33%2M	100.00%2M	0.00%2M	666.67%11.5M	-14.29%6M	0.00%1.5M	-50.00%1M	33.33%2M	-25.00%1.5M
Cash from discontinued financing activities
Financing cash flow	191.67%17.5M	33.33%2M	100.00%2M	0.00%2M	666.67%11.5M	-17.20%6M	0.00%1.5M	-50.00%1M	33.33%2M	-33.21%1.5M
Net cash flow
Beginning cash position	9.62%695K	-13.37%447K	-58.64%311K	-33.73%330K	9.62%695K	9.88%634K	-33.93%516K	13.08%752K	-42.03%498K	9.88%634K
Current changes in cash	-591.80%-300K	-129.05%-52K	157.63%136K	-107.48%-19K	-168.38%-365K	7.02%61K	221.77%179K	-303.45%-236K	230.93%254K	-148.23%-136K
End cash Position	-43.17%395K	-43.17%395K	-13.37%447K	-58.64%311K	-33.73%330K	9.62%695K	9.62%695K	-33.93%516K	13.08%752K	-42.03%498K
Free cash flow	-31.34%-7.8M	-55.34%-2.05M	-50.81%-1.86M	-15.64%-2.02M	-14.00%-1.87M	24.39%-5.94M	19.79%-1.32M	34.39%-1.24M	-3.07%-1.75M	37.79%-1.64M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall